Business & Decision Life Sciences
|Type||Public / Private|
Business & Decision Life Sciences is part of the Business & Decision Group, an international consulting and Systems Integration company founded in 1992 and listed on the Eurolist C exchange.
Business & Decision Life Sciences is specializing in the delivery of services and provision of solutions in the Life Sciences industry. With 20 years of experience, it supports its clients in the pharmaceutical, medical device, biotechnology, food and cosmetics industries.
Core skills include the provision of a range of expert CRO and consulting services (supporting clinical trials in the operational, data management, analytical, outcome research, and document writing area) and the implementation of technology-based, clinical applications and solutions tailored for the Life Sciences industry.
Business & Decision Life Sciences headquarters are located in Brussels, Belgium and has a strong international presence in five countries in North America and Europe.
- Data Publication Services
- CDISC Services
- Clinical Operations
- Biometric Services
- PRO and ePRO Services
- De-identification of data
- SAS Drug Development Support
- Epidemiological Services
- Publication Management
- Pharmacovigilance & Safety
- IS Compliance & Validation
- Compliant Hosting & Managed Services
Phramacovigilance & Safety
Business & Decision Life Sciences provides comprehensive and flexible pharmacovigilance and drug/device services and solutions that are broad in scope, delivering the highest level of regulatory compliance for its clients.
Regulatory agencies expect Life Sciences companies to take a comprehensive and proactive approach to assuring the safety of patients.
In order to fulfill such expectations Life Sciences companies must align organizational processes with regulatory requirements, incentivize the detection and escalation of risks, open and leverage new channels of collaboration, remove traditional barriers between the safety and clinical trials 'silos', and ensure 'C' level ownership of safety issues throughout the organization.
To meet increasing demands for the proactive management of safety issues, intelligent signal detection and analysis must be used for safety events and signals, leveraging new data management and data mining standards. This requires the use of technology which aligns operational and governance processes, standardizes terminology and data models, integrates data from multiple traditional and non-traditional sources and which provides incremental return on investment. Pharmacovigilance and Drug/Device Safety Services
As recognized thought leaders in Life Sciences with significant experience in multiple business domains (drug/device development, clinical, operations, sales & marketing and regulatory compliance), Business & Decision Life Sciences is the ideal choice to assist organizations to meet the growing expectations for pharmacovigilance and drug/device safety.
Business & Decision Life Sciences' broad experience allows them to supplement traditional approaches to product safety (adverse events reporting and signal detection) with a broader, more strategic approach, integrating data and intelligence from the entire product lifecycle.
As an international consultancy and systems integrator specializing in Life Sciences we are able to assist clients in the assessment of their existing processes and systems, to develop Risk Evaluation & Mitigation Strategies (REMS), to advise on the selection of safety tools and systems and to implement and integrate solutions delivering a total safety solution.
Top 5 Recent Tweets
|December 02, 2022||IIB||LISTEN: The director of the Center for the Business of Life Sciences at the @KelleySchool says the decision by Cata… https://t.co/qXLuMhco7P|